- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04581707
Performance and Safety of Joline® Kyphoplasty Single Balloon Catheter Allevo vs. Quattroplasty Double-Balloon Catheter Stop'n GO With BonOs® Inject Bone Cement
Evaluation of Surgical Therapy of Vertebral Compression Fractures With the Kyphoplasty Single Balloon Catheter Allevo (Joline®) and the Quattroplasty Double Balloon Catheter Stop'n GO (Joline®) With BonOs® Inject Bone Cement
Study Overview
Status
Conditions
Detailed Description
Vertebral compression fracture (VCF) is a very common medical problem and describes the collapse of a vertebral body (VB) in the spine. VCF can lead to severe pain, decreased physical function, spinal deformity and in rare cases thoracic or abdominal wall deformities, that can impair pulmonary and gastrointestinal function. A VCF can occur in patients with healthy spines upon severe trauma, in patients suffering from osteoporosis or in patients with metastatic tumors.
Currently available therapy for VCF includes medical management, surgical treatments and vertebral augmentation (VA). Medical management consists of bed rest followed by early mobilization and analgesic medications. Surgical options include spinal stabilization with rods and screws. VA procedures attempt to stabilize the spine and reduce vertical compression by adding material to the spine.
Kyphoplasty is a commonly performed VA procedure. In kyphoplasty, a surgical instrument is used to reduce the collapsed VB towards its original shape. Reduction of the fractured VB is thought to be beneficial since (1) it may reduce anterior directed compressive forces resulting from kyphosis of the spine due to the fracture, and (2) it may reduce some physiologic abnormalities due to kyphosis, such as restrictive lung disease or abdominal compression. After fracture reduction, bone cement is placed in the VB to stabilize the reduction. Fracture reduction follows the orthopedic general principles of fracture repair: reduction and stabilization.
Primary objective of this observational study is to compare the effectiveness of the Quattroplasty double balloon catheter Stop'n GO (Joline®) with the Kyphoplasty single balloon catheter Allevo (Joline®) combined with BonOs® Inject bone cement for use in VCF reduction, to confirm the performance of those two devices and to investigate potential major adverse events associated with the use of the device in patients treated in a controlled setting when used according to the IFU. Secondary objective is to compare the safety of the Quattroplasty double balloon catheter Stop'n GO (Joline®) with the Kyphoplasty single balloon catheter Allevo (Joline®) combined with BonOs® Inject bone cement.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Lisanne Exner
- Phone Number: +4970712986646
- Email: Lisanne.Exner@med.uni-tuebingen.de
Study Contact Backup
- Name: Christian Walter, MD
- Phone Number: +4970712986646
- Email: Christian.Walter@med.uni-tuebingen.de
Study Locations
-
-
-
Tuebingen, Germany, 72076
- Recruiting
- University Hospital for Orthopedics Tuebingen
-
Contact:
- Lisanne Exner
-
Principal Investigator:
- Lisanne Exner
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- patients aged ≥18 years
1-3 painful VCF(s), of which at least 1 meets the following criteria:
- VCF between T7 and L5
- Fracture age <3 months
- VCF shows hyperintense signal on STIR or T2 sequence MRI.
- Investigator estimates that target VB(s) is/ are suitable for Quattroplasty double balloon catheter or Kyphoplasty single balloon catheter (e.g. appropriate pedicle diameter, no cortical bone protruding into the spinal canal).
- Patient has an ODI score of 30% or more.
- Patient is willing and able to comply with study requirements.
- Patient signs informed consent form.
- Women who are post-menopausal, surgically sterile or on contraceptives and agree to remain on contraceptives for the duration of their study participation and agree not to become pregnant during the study.
Exclusion Criteria:
- Segmental kyphosis of target VB of >30°
- Pre-existing or clinically unstable neurologic deficit
- Any physical exam evidence of myelopathy or radiculopathy
- Not able to walk without assistance prior to fractures
- Any radiographic evidence of pedicle fracture or interspinous-process widening
- Spondylolisthesis >grade 1 at target VB(s)
- History of spine surgery, including prior vertebral augmentation, during the last year
- Any underlying systemic bone disease other than osteoporosis (e.g. osteomalacia, osteogenesis imperfect, etc.)
- Irreversible coagulopathy and/or taking peri-operatively warfarin (Coumadin) or other anticoagulant
- Pregnancy and nursing
- Pain due to any other condition that requires daily narcotic medication
- Disabling back pain due to causes other than acute fracture
- History of intolerance, or allergic reaction to titanium or acrylic compounds
- Active systemic or local infection at baseline
- Severe cardiopulmonary disease (e.g. stage IV heart failure, severe chronic obstructive pulmonary disease)
- Any other medical illness or condition that, in the investigator's opinion, is likely to impair long-term follow-up (e.g. cancer) or greatly increase the risk of surgery
- Any evidence of substance abuse
- The patient is on long-term steroid therapy (steroid dose 30 mg/day for >3 months)
- The patient is known to be involved in medical litigation including Workmen's compensation.
- Patient with contraindication for MRI including but not limited to patients with contraindications for general anesthesia (surgeon expertise)
- Patient who is contraindicated for the use of PMMA cement
- Patients who belong to a vulnerable population or that are not able to sign the informed consent form.
- Patients where the VCF was treated in combination with fusion.
- Patients with any contraindication according to the IFU
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Other
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Kyphoplasty Single Balloon Catheter Allevo
|
Vertebral compression fractures treated with Kyphoplasty Single Balloon Catheter Allevo (Joline®) and BonOs® Inject bone cement
|
Quattroplasty Double Balloon Catheter Stop'n GO
|
Vertebral compression fractures treated with Stop'n GO double balloon kyphoplasty system (Joline®) and BonOs® Inject bone cement
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in vertebral body height
Time Frame: pre-operative, 5 days and 3 months post-operatively
|
Change in vertebral body height
|
pre-operative, 5 days and 3 months post-operatively
|
Change in Visual Analog Scale (VAS) of subjective pain
Time Frame: pre-operation, 5 days and 3 months post-operation
|
The Visual Analog Scale (VAS) is a measure for pain intensity.
The score of the sclae ranges from 0 for "no pain" to 10 for "worst imaginable pain".
Patients will report their pain at baseline and at 2 dedicated periods to assess change in pain intensity.
|
pre-operation, 5 days and 3 months post-operation
|
Change in functional disability
Time Frame: pre-operation, 5 days and 3 months post-operation
|
The Oswestry Disability Index (ODI) is used to assess functional disability.
The questionnaire consists of 10 items with each item having 6 statements.
All scores are summed, then multiplied by two to obtain the index (range from 0 to 100) with higher score indicating greater disability.
|
pre-operation, 5 days and 3 months post-operation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Safety Outcomes: Occurence of adverse events and complications
Time Frame: during procedure, 5 days and 3 months post-operation
|
Occurence of adverse events and complications
|
during procedure, 5 days and 3 months post-operation
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Lisanne Exner, University Hopsital for Orthopedics Tuebingen
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- JO-2020Kypho
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vertebral Compression Fracture
-
AgNovos Healthcare, LLCRecruitingVertebral Fracture | Vertebral Compression Fracture | Vertebral CompressionGermany, Spain
-
AgNovos Healthcare, LLCRecruitingVertebral Compression Fracture | Vertebral Compression | Compression FractureUnited States
-
Icahn School of Medicine at Mount SinaiRecruitingVertebral Compression Fractures | Osteoporotic Vertebral Compression FracturesUnited States
-
Jaseng Medical FoundationRecruitingVertebral Compression Fracture | Vertebral Compression | Korean Traditional Medicine | Integrative Korean MedicineKorea, Republic of
-
Optimus Clinical ResearchCareFusionCompletedVertebral Compression Fractures | Osteoporotic Vertebral Compression Fractures | Acute Vertebral FracturesAustralia
-
University Hospital, Clermont-FerrandCompletedVertebrOpLasty Versus Conservative Treatment in Acute Non Osteoporotic Vertebral Fractures (VOLCANO)Vertebral Compression Fracture | Spinal TraumaFrance
-
Northwell HealthCompletedVertebral Fracture | Vertebral Compression | Vertebra Compression FractureUnited States
-
HypreventionCompletedVertebral Compression FractureFrance
-
Hospital for Special Surgery, New YorkCompletedVertebral Compression FractureUnited States
-
Shenzhen People's HospitalCompletedOsteoporotic Vertebral Compression FractureChina
Clinical Trials on Kyphoplasty Single Balloon Catheter Allevo
-
University of California, San FranciscoMedtronics, Inc.CompletedMultiple MyelomaUnited States
-
Centre Leon BerardTerminatedSolid Tumors | Spine MetastasisFrance
-
Medtronic Spine LLCCompletedMultiple Myeloma | Bone Neoplasms | Osteoporosis | OsteopeniaUnited States
-
Mayo ClinicCompleted
-
Assistance Publique - Hôpitaux de ParisTerminatedMultiple Myeloma | Vertebral Fracture | Osteolytic MetastasesFrance
-
Stryker InstrumentsTalosixActive, not recruiting
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, FranceCompletedSPINAL FractureFrance
-
Synthes GmbHCompletedVertebral Body FracturesGermany, Austria
-
Vanderbilt University Medical CenterSandhill ScientificEnrolling by invitationGastro Esophageal RefluxUnited States
-
Vexim SAACES Ing.-GmbHCompletedOsteoporosis | Spinal Fractures | Back Injuries | Vertebral Compression FracturesSpain, France, Switzerland, Germany, Italy